Studio Investment Management’s Houlihan Lokey HLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$503K Sell
3,750
-11
-0.3% -$1.62K 0.09% 128
2026
Q1
$540K Buy
3,761
+47
+1% +$7.73K 0.1% 117
2025
Q4
$647K Sell
3,714
-50
-1% -$9.18K 0.12% 108
2025
Q3
$773K Sell
3,764
-146
-4% -$28.6K 0.15% 98
2025
Q2
$704K Sell
3,910
-35
-0.9% -$5.88K 0.14% 96
2025
Q1
$637K Sell
3,945
-473
-11% -$81.2K 0.13% 103
2024
Q4
$767K Sell
4,418
-126
-3% -$22.2K 0.16% 86
2024
Q3
$718K Sell
4,544
-155
-3% -$23.2K 0.15% 91
2024
Q2
$634K Sell
4,699
-3
-0.1% -$393 0.14% 91
2024
Q1
$603K Buy
4,702
+354
+8% +$43.8K 0.14% 94
2023
Q4
$521K Sell
4,348
-818
-16% -$88.7K 0.13% 94
2023
Q3
$553K Sell
5,166
-194
-4% -$20K 0.15% 75
2023
Q2
$527K Buy
5,360
+391
+8% +$35.4K 0.15% 76
2023
Q1
$435K Buy
+4,969
New +$468K 0.13% 84

Other funds holding HLI

Studio Investment Management's HLI Position: Q2 2026 in Review

Studio Investment Management reduced its Houlihan Lokey (HLI) stake by 0.29% in Q2 2026, selling an estimated $1.62K and leaving 3,750 shares worth $503K. The position accounts for 0.09% of the portfolio, ranked #128.

Studio Investment Management first reported a position in HLI in Q1 2023 and has held it in 14 quarters since. The position peaked at $773K in Q3 2025. 515 funds tracked by Wall St. Rank hold HLI as of Q2 2026.

  • Studio Investment Management held 3,750 shares of Houlihan Lokey worth $503K as of Q2 2026.
  • Studio Investment Management sold 11 Houlihan Lokey shares in Q2 2026, an estimated $1.62K.
  • Houlihan Lokey made up 0.09% of Studio Investment Management's portfolio in Q2 2026, its #128 holding.
  • Studio Investment Management first reported a position in Houlihan Lokey in Q1 2023 and has held it in 14 quarters since.
  • Studio Investment Management's Houlihan Lokey position peaked at $773K in Q3 2025.
  • 515 funds tracked by Wall St. Rank held Houlihan Lokey as of Q2 2026.

Based on Studio Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.